In the mutant β-amyloid precursor protein (APP), known as the London model for AD, plaques are usually observed around the age of 12–15 months while in the APP/London X Presenilin-1 double-transgenic mice the same plaques are observed at the age of 6 months [9]. This evidence concerns the gene APP and Alzheimer disease.